Vigonvita Life Sciences
Clinical trials sponsored by Vigonvita Life Sciences, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New depression drug LV232 enters Mid-Stage trial Results expected Sep 2026 (estimated)
- New drug VV913 put to the test in healthy volunteers Results expected Sep 2026 (estimated)
- Could a new pill for schizophrenia pass its first human test? Results expected Oct 2026 (estimated)
- Does breakfast change how this drug works? new study aims to find out Results expected Oct 2026 (estimated)
- New schizophrenia drug VV119 enters early human testing Results expected Oct 2026 (estimated)